How to confirm or deny high-risk thyroid carcinoma is a challenge for pathologists-Reference-Cited by-同舟云学术

How to confirm or deny high-risk thyroid carcinoma is a challenge for pathologists

Published:2016-12-20 Issue:3 Volume:67 Page:179-180
ISSN:1320-5463
Container-title:Pathology International
language:en
Short-container-title:Pathol Int

Author:

Kakudo Kennichi¹,Asai Masami²,Bai Yanhua³

Affiliation:

1. Department of Pathology; Nara Hospital Kindai University Faculty of Medicine; Japan

2. Department of Pathology; Nagoya Kyoritsu Hospital; Japan

3. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education); Department of Pathology; Peking University Cancer Hospital & Institute; China

Publisher

Wiley

Subject

General Medicine,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/pin.12498/fullpdf

Reference5 articles.

1. Case report. Squamous cell components in a thyroid follicular adenoma: Significant evidence of follicular cell origin by histomorphological, immunohistochemical and molecular analyses;Bai;Pathol Int,2011

2. Histopathological analysis of anaplastic thyroid carcinoma cases with long-term survival: A report from the anaplastic thyroid carcinoma research consortium of Japan;Hirokawa;Endocr J,2016

3. Benign nodular goiter with spindle cell component;Hirokawa;Pathol Int,2010

4. Prognostic classification of thyroid follicular cell tumors using Ki-67 labeling index: Risk stratification of thyroid follicular cell carcinoma;Kakudo;Endocr J,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anaplastic Thyroid Carcinoma;Thyroid FNA Cytology;2023

2. Emerging Biomarkers in Thyroid Practice and Research;Cancers;2021-12-31

3. How to identify indolent thyroid tumors unlikely to recur and cause cancer death immediately after surgery—Risk stratification of papillary thyroid carcinoma in young patients—;Endocrine Journal;2021

4. Anaplastic Thyroid Carcinoma;Thyroid FNA Cytology;2019

5. The new 4th edition World Health Organization classification for thyroid tumors, Asian perspectives;Pathology International;2018-12